Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Endogenous fungal endophthalmitis: international, multicentre, retrospective analysis of clinical outcomes following surgical and medical management, and screening

This article has been updated

Abstract

Objectives

To report the clinical outcomes of surgical management versus medical management alone in cases of endogenous fungal endophthalmitis. Additionally, we explore the role of routine ophthalmic screening.

Methods

Retrospective observational multicentre study. We examined the databases of five UK centres and a tertiary centre in the United States for patients with Candida septicaemia (candidemia) and/or clinically established endogenous fungal endophthalmitis. Clinical data including visual acuity and other outcomes were reviewed and analysed with statistics.

Results

A total of 404 patients were included from all centres. Forty-six eyes were diagnosed clinically as presumed EFE - of which 25 were later confirmed with positive vitreous biopsies. 18/46 received systemic medical treatment with or without intravitreal injection of antifungal agents and without a significant logMAR vision improvement from 1.15 ± 0.29 at baseline to 0.74 ± 0.21 at last follow up. The remaining 28/46 eyes received both systemic medical treatment and vitrectomy, and visual acuity improved from 1.56 ± 0.19 to 1.14 ± 0.21 after surgery (p = 0.04). At the last follow up, 18/28 eyes (64.3%) had an attached retina with no tamponade, three attached under oil and two ending up with detached retina. Silicone oil was retained in three eyes due to either patient comorbidities precluding further surgery or due to surgeon preference to ensure long-term anatomical stability. Two cases resulted in macular and/or fibrovascular scarring and one in enucleation. Out of 359 patients with candidemia, 95 (26.4%) had ophthalmological examination and only 9 (9.47% of those examined and 2.5% of the total) had endogenous fungal endophthalmitis (7 confirmed with vitreous sample cultures and 2 presumed).

Conclusion

Although our findings suggest that vitrectomy may improve outcomes in select cases of EFE, the retrospective nature of our study and the potential for bias mandate cautious interpretation. Therefore, further prospective studies are necessary to shed more light with novel insights. A more targeted, case-by-case screening paradigm for patients with candidemia is advocated for optimum outcomes and efficient use of resources.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

The raw data (excel sheet) that support the findings of this study are available upon request from the corresponding author (A.W.).

Change history

  • 12 November 2025

    In this article the acknowledgement section has been modified. The following sentence is added: The authors gratefully acknowledge Dr. Kashika Singh, BMBS, BMedSci (Hons), and Dr. Haytham Rezq, who were affiliated with University Hospital Southampton NHS Foundation Trust at the time of data collection, for their valuable contribution to the acquisition of data supporting this work. Dr. Singh is currently affiliated with Worcestershire Acute Hospitals Trust, and Dr. Rezq is currently affiliated with Magrabi Health Hospitals and Centres.

References

  1. Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153:162–6.

    Article  PubMed  Google Scholar 

  2. Schiedler V, Scott IU, Flynn Jr HW, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137:725–31.

    PubMed  Google Scholar 

  3. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.

    Article  CAS  PubMed  Google Scholar 

  4. Menezes AV, Sigesmund DA, Demajo WA, Devenyi RG. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med. 1994;154:2093–7.

    Article  CAS  PubMed  Google Scholar 

  5. Breazzano MP, Tooley AA, Godfrey KJ, Iacob CE, Yannuzzi NA, Flynn HW. Candida auris and endogenous panophthalmitis: clinical and histopathological features. Am J Ophthalmol Case Rep. 2020;19. https://pubmed.ncbi.nlm.nih.gov/32462100/ [Accessed October 18, 2024].

  6. Kostick DA. Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol. 1992;113:593–5.

    Article  CAS  PubMed  Google Scholar 

  7. Sridhar J, Flynn HW, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3:1–6.

    Article  Google Scholar 

  8. Thangamathesvaran L, Canner JK, Scott AW, Woreta FA, Breazzano MP. National emergency department trends for endogenous endophthalmitis: an increasing public health challenge. Eye. 2023;37:1123–9.

    Article  PubMed  Google Scholar 

  9. Dutta Majumder P. Endogenous fungal endophthalmitis in COVID-19 patients: an unexplored possibility. Indian J Ophthalmol. 2022;70:1083–5.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kim DY, Moon HI, Joe SG, Kim JG, Yoon YH, Lee JY. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea. J Korean Med Sci. 2015;30:960–4.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Chakrabarti A, shivaprakash MR, Singh R, Tarai B, George VK, Fomda BA, et al. Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina. 2008;28:1400–7.

    Article  PubMed  Google Scholar 

  12. Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB. Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine. 1974;53:47–75.

    Article  PubMed  Google Scholar 

  13. Parke DW II, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89:789–96.

    Article  PubMed  Google Scholar 

  14. Krishna R, Amuh D, Lowder CY, Gordon S, Hall G, Adal K. Should all patients with candidemia have an ophthalmologic examination to rule out ocular candidiasis? Clinical Infect Dis. 1997;25:439.

    Google Scholar 

  15. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin infect Dis. 2015;62:e1–e50. https://academic.oup.com/cid/article-abstract/62/4/e1/2462830 [Accessed April 22, 2024].

  16. Royal College of Ophthalmologists. Eye care in the intensive care unit (ICU). The Royal College of Ophthalmologists, Ophthalmic services guidance; April 2020. https://www.rcophth.ac.uk/wp-content/uploads/2021/01/Eye-Care-in-the-Intensive-Care-Unit-2020.pdf.

  17. Priluck A, Huang P, Breazzano MP. Outcomes and clinical features predictive of fungal endophthalmitis. Am J Ophthalmol. 2023. https://www.sciencedirect.com/science/article/pii/S0002939423000685 [Accessed October 18, 2024].

  18. Day HR, Bond JB, Gupta B, Saeed K, Breazzano MP. Should routine eye examinations be included in treatment bundles for patients with candidemia? J Infect Dis. 2021, https://academic.oup.com/jid/article-abstract/224/9/1626/6209464 [Accessed September 14, 2024].

  19. Breazzano MP, Bond JB, Bearelly S, Kim DH, Donahue SP, Lum F, et al. American Academy of Ophthalmology recommendations on screening for endogenous Candida endophthalmitis. Ophthalmology. 2022;129:73–76.

    Article  PubMed  Google Scholar 

  20. Sallam A, Taylor SRJ, Khan A, McCluskey P, Lynn WA, Manku K, et al. Factors determining visual outcome in endogenous Candida endophthalmitis. Retina. 2012;32:1129–34.

    Article  PubMed  Google Scholar 

  21. Chen KJ, Sun MH, Chen YP, Chen YH, Wang NK, Liu L, et al. Endogenous fungal endophthalmitis: causative organisms, treatments, and visual outcomes. J Fungi. 2022;8:641.

    Article  Google Scholar 

  22. Moussa G, Bassilious K, Mathews N. A novel excel sheet conversion tool from Snellen fraction to LogMAR including ‘counting fingers’, ‘hand movement’, ‘light perception’ and ‘no light perception’ and focused review of literature of low visual acuity reference values. Acta Ophthalmol. 2021; 99: e963–e965. https://onlinelibrary.wiley.com/doi/full/10.1111/aos.14659 [Accessed October 18, 2024].

  23. Tabatabaei SA, Aminzade S, Ahmadraji A, Soleimani M, Sefidan BB, Kasaee A, et al. Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi-experimental study. BMC Ophthalmol. 2022;22:16.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dib B, Morris RE, Oltmanns MH, Sapp MR, Glover JP, Kuhn F. Complete and early vitrectomy for endophthalmitis after cataract surgery: an alternative treatment paradigm. Clin Ophthalmol. 2020;14:1945–54. https://www.tandfonline.com/doi/abs/10.2147/OPTH.S253228 [Accessed April 22, 2024].

  25. Grzybowski A, Turczynowska M, Kuhn F. The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? Acta Ophthalmol. 2018;96:e651–e654.

    Article  PubMed  Google Scholar 

  26. Priluck AZ, Huang P, Breazzano MP. Outcomes and clinical features predictive of fungal endophthalmitis. Am J Ophthalmol. 2023;251:104–14.

    Article  PubMed  Google Scholar 

  27. Payne JF, Keenum DG, Sternberg P, Thliveris A, Kala A, Olsen TW. Concentrated intravitreal amphotericin B in fungal endophthalmitis. Arch Ophthalmol. 2010;128:1546–50.

    Article  PubMed  Google Scholar 

  28. Haseeb AA, Elhusseiny AM, Siddiqui MZ, Ahmad KT, Sallam AB. Fungal endophthalmitis: a comprehensive review. J Fungi. 2021;7:996.

    Article  Google Scholar 

  29. Lupia T, Corcione S, Fea AM, Reibaldi M, Fallico M, Petrillo F, et al. Exogenous fungal endophthalmitis: clues to Aspergillus aetiology with a pharmacological perspective. Microorganisms. 2020;9:74.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Schimel AM, Miller D, Flynn HW Jr. Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol. 2013;156:50–52.

    Article  CAS  PubMed  Google Scholar 

  31. Spadea L, Giannico MI. Diagnostic and management strategies of aspergillus endophthalmitis: current insights. Clinical Ophthalmol. 2019;13:2573–82.

    Article  Google Scholar 

  32. Das T, Agarwal M, Anand AR, Behera UC, Bhende M, Das AV, et al. Fungal endophthalmitis: analysis of 730 consecutive eyes from 7 tertiary eye care centers in India. Ophthalmol Retin. 2022;6:243–51.

    Article  Google Scholar 

  33. Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous endophthalmitis: a review of case series published between 2011 and 2020. J Ophthalmol. 2020, https://onlinelibrary.wiley.com/doi/abs/10.1155/2020/8869590 [Accessed October 20, 2024].

  34. Nguyen N-H, Nguyen M-P, Nguyen HPT, Mai HK, Do ST, Ho HX, et al. Endogenous endophthalmitis in children: a 5-year retrospective study in Vietnam. J Pediatr Ophthalmol Strabismus. 2025. https://journals.healio.com/doi/abs/10.3928/01913913-20250404-04 [Accessed June 29, 2025].

  35. El-Abiary M, Jones B, Williams G, Lockington D. Fundoscopy screening for intraocular candida in patients with positive blood cultures—is it justified? Eye. 2018. https://www.nature.com/articles/s41433-018-0160-x [Accessed May 5, 2024].

  36. Breazzano MP, Day HR, Bloch KC, Tanaka S, Cherney EF, Sternberg P, et al. Utility of ophthalmologic screening for patients with candida bloodstream infections: a systematic review. JAMA Ophthalmol. 2019;137:698–710.

    Article  PubMed  Google Scholar 

  37. Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, et al. The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia. PLoS One. 2019;14:e0216956.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Vena A, Muñoz P, Padilla B, Valerio M, Sanchez MI, Puig-Asensio M, et al. Is routine ophthalmoscopy really necessary in candidemic patients? PLoS One. 2017;12:e0183485.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Danielescu C, Stanca HT, Iorga RE, Darabus DM, Potop V. The diagnosis and treatment of fungal endophthalmitis: an update. Diagnostics. 2022;12:679.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Patel TP, Zacks DN, Dedania VS. Antimicrobial guide to posterior segment infections. Graefe’s Arch Clin Exp Ophthalmol. 2021;259:2473–501.

    Article  Google Scholar 

  41. Patterson TF, Thompson Iii GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 63: e1–e60. https://academic.oup.com/cid/article-abstract/63/4/e1/2595039 [Accessed April 22, 2024].

  42. Yoshida M, Kiyota N, Maruyama K, Kunikata H, Toyokawa M, Hagiwara S, et al. Endogenous fusarium endophthalmitis during treatment for acute myeloid leukemia, successfully treated with 25-gauge vitrectomy and antifungal medications. Mycopathologia. 2018;183:451–7.

    Article  CAS  PubMed  Google Scholar 

  43. Rizzello I, Castagnetti F, Toschi PG, Bertaccini P, Primavera L, Paolucci M, et al. Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia. Mycoses. 2018;61:53–60.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge Dr. Kashika Singh, BMBS, BMedSci (Hons), and Dr. Haytham Rezq, who were affiliated with University Hospital Southampton NHS Foundation Trust at the time of data collection, for their valuable contribution to the acquisition of data supporting this work. Dr. Singh is currently affiliated with Worcestershire Acute Hospitals Trust, and Dr. Rezq is currently affiliated with Magrabi Health Hospitals and Centres.

Author information

Authors and Affiliations

Authors

Contributions

AW: Organising data, data analysis and statistics, writing the manuscript. DK: Writing the manuscript. BG: Study idea and design. Communication with other centres. Supervising the whole process. Review. MB, KS, DS, AC, RH: Review and revision of manuscript. Southampton data collection team: BG, KS. Newcastle data collection team: RH, KN, IM, MN. St. Thomas’ data collection team: TW, NK. Sunderland data collection team: DS. SUNY, New York data collection team: MB, NG, JH.

Corresponding author

Correspondence to Amr Wassef.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wassef, A., Breazzano, M.P., Saeed, K. et al. Endogenous fungal endophthalmitis: international, multicentre, retrospective analysis of clinical outcomes following surgical and medical management, and screening. Eye 39, 3249–3256 (2025). https://doi.org/10.1038/s41433-025-04061-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41433-025-04061-0

Search

Quick links